Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, june 2013

Eurosurveillance

Volumn 18, Issue 36, 2013, Pages

  Perera, R A ^a   Wang, P ^b,c   Gomaa, M R ^d   El Shesheny, R ^d   Kandeil, A ^d   Bagato, O ^d   Siu, L Y ^b   Shehata, M M ^d   Kayed, A S ^d   Moatasim, Y ^d   Li, M ^b   Poon, L L ^a   Guan, Y ^a   Webby, R J ^e   Ali, M A ^d   Peiris, J S ^a   Kayali, G ^e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d NATIONAL RESEARCH CENTRE   (Egypt)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CAMEL; CHILD; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; COW; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; SEROEPIDEMIOLOGY; VIRUS NEUTRALIZATION; VIRUS STRAIN; WATER BUFFALO;

EID: 84884232066     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2013.18.36.20574     Document Type: Article

References (17)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-20. http://dx.doi.org/10.1056/NEJMoa1211721. PMid:23075143
2. World Healh Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV) - update. Geneva: WHO; 29 Aug 2013. Available from: http://www.who.int/csr/ don/2013_08_29/en/index.html
3. World Healh Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update - as of 9 July 2013. Geneva: WHO. [Accessed 20 Aug 2013]. Available from: http://www.who.int/csr/disease/ coronavirus_infections/update_20130709/en/index.html
4. Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012;17(40):pii=20290. http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20290
5. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369(5):407-16. http://dx.doi.org/10.1056/ NEJMoa1306742. PMid:23782161
6. Annan A, Baldwin HJ, Corman VM, Klose SM, Owusu M, Nkrumah EE, et al. Human betacoronavirus 2c EMC/2012vrelated viruses in bats, Ghana and Europe. Emerg Infect Dis. 2013;19(3):456-9. http://dx.doi.org/10.3201/eid1903.121503. PMid:23622767. PMCid:PMC3647674
7. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis. 2013. EPub ahead of print. DOI: 10.3201/ eid1910.130946. http://dx.doi.org/10.3201/eid1910.130946
8. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis. 2013. EPub ahead of print. DOI: 10.3201/eid1911.131172. http://dx.doi.org/10.3201/ eid1911.131172
9. Cao WC, Liu W, Zhang PH, Zhang F, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357(11):1162-3. http://dx.doi. org/10.1056/NEJMc070348. PMid:17855683
10. Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013; pii: S1473-3099(13)70164-6. DOI: 10.1016/S1473-3099(13)70164-6. http://dx.doi.org/10.1016/S1473-3099(13)70164-6
11. Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012;17(49):pii=20334. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20334
12. Reusken C, Mou H, Godeke GJ, van der Hoek L, Meyer B, Muller MA, et al. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill. 2013;18(14):20441. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20441.PMid:23594517
13. Garcia JM, Lagarde N, Ma ES, de Jong MD, Peiris JS. Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay. J Clin Virol. 2010;47(1):29-33. http://dx.doi.org/10.1016/j. jcv.2009.10.009. PMid:19897409
14. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A, et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol. 2013;87(10):5502-11. http://dx.doi. org/10.1128/JVI.00128-13. PMid:23468491
15. Saif LJ. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Rev Sci Tech. 2004;23(2):643-60. PMid:15702725
16. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302(5643):276-8. http://dx.doi.org/10.1126/ science.1087139. PMid:12958366
17. Li F. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J Virol. 2008;82(14):6984-91. http://dx.doi.org/10.1128/JVI.00442-08. PMid:18448527. PMCid:PMC2446986.